I do agree with you, especially with biotech’s that produce no revenue, you see it time and time again these small companies burn through cash quarter after quarter. I like the idea of staying lean and focus on getting one foot in the door. However, it makes you wonder if Dan Browne has partnership plans already in place knowing full well RVNC will not be paying for these trials.
News 
Market Data 
Discover 
